Navigation Links
Genetic testing may help select women with ER+ breast cancer for extended hormone therapy
Date:3/19/2014

e confirmed in other sets of tumours first. "This should be done by testing the tumours of patients that are participating in ongoing trials of extended versus no extended adjuvant therapy," said Prof Dowsett.

Prof Cuzick added: "It has long been known that women with ER+ cancers have a higher late recurrence rate than those with ER-negative tumours. This work makes clear that even within ER+ cancers the level of expression is important. Further work is needed to see if genetic expression profiles are better at doing this than more conventional quantitative immunohistochemistry. We are about to start a trial called IBIS-3 of extended therapy with aromatase inhibitors in long-term survivors with ER+ breast cancer with other unfavourable characteristics, and also adding new drugs used in other conditions that show promise in preventing breast cancer recurrence a bisphosphonate (bone sparing drug) and metformin (diabetes drug). Hopefully, this biomarker work will help to pinpoint more accurately which patients need additional treatment."

Professor Giuseppe Viale, chair of EBCC-9 and Head of the Department of Pathology at the University of Milan, commented: ""Late recurrence for patients with hormone receptor-positive breast cancer after five years of endocrine treatment unfortunately is a sizeable risk, with devastating effects on the quality of life of affected patients. Clinical trials have already documented the possible benefit of extending endocrine therapy beyond five years in unselected populations of post-menopausal patients, but we do not have the means to identify the subgroup of patients actually benefitting from this extended treatment. These latest findings from the ATAC trial may pave the way for a better tailoring of hormone therapy beyond the first five years. Certainly, confirmatory studies are needed, and it remains to be assessed whether the same prognostic parameters may also hold for pre-menopausal patients."


'/>"/>

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Genetic test could improve colon cancer screening
2. Sea anemone is genetically half animal, half plant
3. Fly meeting to spotlight research advances in genetics
4. Rice synthetic biologists shine light on genetic circuit analysis
5. Sudden cardiac death: Genetic disease ARVC more common than hitherto assumed
6. CHOP researcher finds more genetic signals linking weight and heart health risk factors
7. New tool to unlock genetics of grape-growing
8. Researchers at LSTM crack the genetic secret of mosquito resistance to DDT and ITNs
9. New study shows a genetic link between feeding behavior and animal dispersal
10. Compound improves cardiac function in mice with genetic heart defect, MU study finds
11. Genetics linked to children viewing high amounts of violent media
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2015)... Mass., July 23, 2015 Aware, Inc. (NASDAQ: ... today reported financial results for its second quarter ended June ... of 2015 was $4.5 million, a decrease of 33% compared ... income in the second quarter of 2015 was $0.3 million, ... or $0.04 per diluted share, in the same period a ...
(Date:7/20/2015)... , July 20, 2015  Acuity Market Intelligence,s ... The Convergence of Commerce and Privacy" forecasts that ... biometric apps will be downloaded to smart mobile ... mobile biometrics market is projected to generate more ... during the seven-year forecast period.    ...
(Date:7/9/2015)... July 9, 2015  Unchained Labs just can,t ... acquisition of Avid Nano. Avid Nano designs, develops ... systems.    Also today, Unchained Labs ... easiest to use protein sizing system. The pUNk ... protein,s hydrodynamic size, size distribution, aggregation population and ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
... around the world are joining efforts to demonstrate ... symposium on "Maintaining health with nutrient rich diets: ... syndrome, cardiovascular disease (CVD), obesity and sarcopenia." ... of Nutritional Science (IUNS) Congress of Nutrition, taking ...
... for generating part of the skeletal support for the ... Now, Jean-Franois Joanny from the Physico Chemistry Curie Unit ... found that a well-defined layer beneath the cell outer ... generated by motor proteins within the cellular system. These ...
... who are HIV positive don,t know it, yet testing and ... international standards of cost-effectiveness and save millions of lives ... population every five years according to a new study published ... are based on a careful analysis of India,s HIV epidemic ...
Cached Biology News:First international collaboration to showcase latest body of evidence of dairy health benefits 2Cost-effective: Universal HIV testing in India 2Cost-effective: Universal HIV testing in India 3Cost-effective: Universal HIV testing in India 4
(Date:7/30/2015)... 2015 AACC welcomed thousands of medical ... Annual Meeting & Clinical Lab Expo in ... meeting showcased revolutionary advancements in clinical testing technology ... providers to diagnose patients quickly and accurately and ... As of Wednesday, July 29, more ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... has appointed Francois Vieillard as Sales & Marketing Director. , With more ... Vieillard will be responsible for reinforcing Tronics’ business development activities worldwide. He brings ...
(Date:7/30/2015)... , July 30, 2015 According ... Product (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity ... Development, Preclinical, Clinical Trial), by End Users - Global ... is expected to reach USD 2,107.99 million by 2020 ... of 15.29%. Browse more than ...
(Date:7/30/2015)... Kan. , July 30, 2015   ... a pet therapeutics company focused on the licensing, ... companion animals, today announced that its strategic partner ... a dose confirmation study of AT-016, an adipose-derived ... for the treatment of osteoarthritis pain in dogs. ...
Breaking Biology Technology:Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Tronics appoints Francois Vieillard as Sales and Marketing Director 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5
... Wis. - Alfalight, Inc., announced the release ... in two configurations for delivery in September. , ,The CPM-II ... 200-micron (0.22 NA) output fiber for fiber laser applications. A ... 5/125 micron signal/pump fiber) is also available for fiber amplifier ...
... had a chance to dig into some more music. A constant reminder ... I am hoping that he is the next Jonny Lang who will ... a week of rock 'n roll camp. , ,Can you imagine this: ... This kind of reminded me of the movie "School of Rock" with ...
... company hires an independent computer programmer to write software. All ... important part of its business. All too often as well, ... a written contract, the specifics of ownership of the intellectual ... later (perhaps as a result of the sale of the ...
Cached Biology Technology:Historic lists - The greatest rock bands, rock guitarists of all time 2Historic lists - The greatest rock bands, rock guitarists of all time 3Historic lists - The greatest rock bands, rock guitarists of all time 4Who owns software developed for your company? 2Who owns software developed for your company? 3Who owns software developed for your company? 4
... The Transcend Non-Radioactive Translation Detection Systems ... in vitro. Using these systems, biotinylated ... proteins during translation, eliminating the need ... radioactive amino acids. This biotinylated lysine ...
...
... Maximize the value of your microarray ... offer the support you need from ... the most up to date methods. ... the Gene Expression Profiling Service or ...
... your microarray data using Asuragens bioinformatics expertise. ... consultation to extensive data analysis using the ... expertise in combination with the Gene Expression ... experiments., ,Normalization and basic statistical analysis including ...
Biology Products: